NQO1 and cancer: Co-treatment with either 108 or 109 and β-lapachone (110), known to excessively generate ROS in living cells upon reduction to 111 by NQO1,200 induced efficient degradation of the respective POI in cancer cells, while negligible effects were observed in noncancerous cells.194